- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
溶栓评估与再通选择演示讲稿.ppt
急性脑梗死诊治热点:溶栓出血预测及血管再通方法选择;血管再通方法Methods in recanalization;Fast recanalization and subsequent reperfusion is the main objective to be achieved in acute ischemic stroke with arterial occlusion
To date, the most effective therapy for treatment of acute ischemic stroke is intravenous rtPA (4.5hours)
Other methods of recanalization became hot topics in recent years because of limitations of iv rtPA.
;Limitations of iv. rtPA;静脉溶栓美国新推荐;溶栓后症状性颅内出血预测量表研究 HAT SPAN-100 SITS THRIVE;Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, Searls D, Selim M.
The?HAT?Score: a simple grading scale for predicting?hemorrhage?after ?thrombolysis. Neurology. 2008;71(18):1417-23.;;THRIVE (Totaled Health Risks in Vascular Events)量表;
THRIVE量表
能在亚洲人群(尤其是中国人)预测出血转化风险吗?;本期推荐阅读文章;社论:21世纪预后估计与卒中治疗的艺术;用2分作为分界点评估出血转化的风险
(心源性脑梗死:敏感性:62.5%,特异性:73.5%;非心源性脑梗死:敏感性:71.2%,特异性: 65.6%)
; THRIVE量表预测出血转化的ROC曲线,无论是心源性脑梗死还是非心源性脑梗死其ROC曲线值都大于0.5(心源性脑梗死: ROC=0.602 ;非心源性脑梗死:ROC=0.608 )
;;动脉溶栓Intra-arteral thrombolysis;What about the Evidence?;PROACT II Trial;What about the Evidence?;Meta-analysis of RCTs;Meta-analysis of RCTs; 桥接 (Bridging) Combined IV and IA thrombolysis;Combined (Bridging) Therapy;Bridging Therapy;Bridging Therapy; The?Interventional?Management?of?Stroke?(IMS-III?trial )
The patients who had received intravenous t-PA within 3 hours after symptom onset were randomly assigned to receive additional endovascular therapy or intravenous t-PA alone, in a 2:1 ratio
The primary outcome measure: a modified Rankin scale score of 2 or less at 90 days; ( The?Interventional?Management?of?Stroke?(IMS)-III?trial )
The study was stopped early because of futility after 656 participants had undergone randomization (434 patients to endovascular therapy and 222 to intravenous t-PA alone)
The primary outcome measure did not differ significantly according to treatment (40.8% VS 38.7%, endovascular therapy VS intravenous t-PA)
The endovascular therapy after intravenous t-PA showed
原创力文档


文档评论(0)